Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | 0.00% | +1.64% | +39.91% |
05-07 | Top Premarket Gainers | MT |
05-06 | Transcript : FibroGen, Inc., Q1 2024 Earnings Call, May 06, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.91% | 123M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.39% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- FGEN Stock
- News FibroGen, Inc.
- FibroGen : Goldman Sachs Downgrades FibroGen to Sell Rating From Neutral, Adjusts Price Target to $11 From $16